Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrially encoded NADH dehydrogenase 2 pseudogene (ENSG00000283381) is a pseudogene sequence with high similarity to the functional mitochondrial gene MT-ND2, which encodes a subunit of the NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial electron transport chain. As a pseudogene, ENSG00000283381 does not code for a functional protein and is not considered a therapeutic target, receptor, enzyme, or transporter. There are no established aliases beyond MT-ND2 pseudogene, and there are no biological functions, disease roles, drug interactions, mechanisms of action, biomarkers, or safety concerns associated with this sequence, as it is a non-functional genomic relic[1][3][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH dehydrogenase 2 pseudogene.